FDA Inspection 1008520 — MedStar Georgetown Medical Center Inc Georgetown University Hospital
The FDA completed an inspection of MedStar Georgetown Medical Center Inc Georgetown University Hospital on March 24, 2017 in Washington, DC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 24, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Washington, DC (United States)